Avanos Medical (AVNS)
(Delayed Data from NYSE)
$20.39 USD
-0.03 (-0.15%)
Updated May 17, 2024 04:00 PM ET
After-Market: $20.42 +0.03 (0.15%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth C Momentum D VGM
Brokerage Reports
AVANOS MEDICAL, INC. [AVNS]
Reports for Purchase
Showing records 101 - 120 ( 242 total )
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Gross Margin Headwinds Continue to Weigh on NT Results
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: AVANOS MEDICAL, INC.
Industry: Medical - Instruments
Optically Looks OK, but Mix and Gross Margin Were Negatives
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department